ArticleMediterranean journal of hematology and infectious diseases2023
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.
Giovanni Manfredi Assanto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.